No Data
No Data
Verona Pharma Announces December 2024 Investor Conference Participation
Verona Pharma Plc's (NASDAQ:VRNA) Path To Profitability
Druckenmiller made significant adjustments in the third quarter: opened positions in Bank of America and Broadcom, continued to increase holdings in the top position Natera.
Natera's position significantly increased by 80.61% compared to the previous quarter. Druckenmiller also established new positions in Broadcom, banks, and pharmaceutical stocks, while completely liquidating News Corp and telecom company Liberty Global, and reducing shareholding in microsoft.
Druckenmiller's Duquesne Closes Some Media Holdings, Loads Into Regional Banks, Among Q3 Trades
Truist Financial Maintains Verona Pharma(VRNA.US) With Buy Rating
Form 144 | Verona Pharma(VRNA.US) Officer Proposes to Sell 4.82 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $Verona Pharma(VRNA.US)$ Officer MARK HAHN intends to sell 125K shares of its common stock on Nov 11, with a total market value of approximately $4.82 million.
No Data
No Data